The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.
Open accessAbstract
Bacterial lipopolysaccharide (LPS) and a diverse array of other immunostimulants and cytokines suppress the metabolism of endogenous and exogenous substances by reducing activity of the hepatic cytochrome P450 mixed-function oxidase system. Although this effect of immunostimulants was first described almost 40 yr ago, the mechanism is obscure. Immunostimulants are now known to cause NO overproduction by cells via induction of nitric oxide synthase. We have investigated whether NO overproduction is involved in suppressing hepatic metabolism by LPS. In vitro treatment of hepatic microsomes with NO, produced by chemical decomposition of 3-morpholinosydnonimine or by nitric oxide synthase, substantially suppressed cytochrome P450-dependent oxygenation reactions. This effect of NO was seen with hepatic microsomes prepared from two species (rat and chicken) and after exposure to chemicals that induce distinct molecular isoforms of cytochromes P450 (beta-naphthoflavone, 3-methylcholanthrene, and phenobarbital). Spectral studies indicate that NO reacts in vitro with both Fe(2+)- and Fe(3+)-hemes in microsomal cytochromes P450. In vivo, LPS diminished the phenobarbital-induced dealkylation of 7-pentoxyresorufin by rat liver microsomes and reduced the apparent P450 content as measured by CO binding. These LPS effects were associated with induction of NO synthesis; LPS-induced NO synthesis showed a strong positive correlation with the severity of cytochrome P450 inhibition. The decrease in both hepatic microsomal P450 activity and CO binding caused by LPS was largely prevented by the selective NO synthase inhibitor N omega-nitro-L-arginine methyl ester. Our findings implicate NO over-production as a major factor mediating the suppression of hepatic metabolism by immunostimulants such as LPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82245-5 · Cited by 3,489
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7674 · Cited by 1,238
Greenlee, W. F., & Poland, A. (1978) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31268-1 · Cited by 622
Reactions and significance of cytochrome P-450 enzymes
Guengerich, F. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99177-5 · Cited by 599
Phenobarbital induction of cytochrome P-450 gene expression
Waxman, D. J., & Azaroff, L. (1992) · Biochemical Journal · doi:10.1042/bj2810577 · Cited by 532
Mammalian Nitric Oxide Synthases
Stuehr, D. J., & Griffith, O. W. (1992) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123119.ch8 · Cited by 508
Gross, S. S., & Levi, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35667-9 · Cited by 443
Self-citationAisaka, K., Gross, S. S., Griffith, O. W., & Levi, R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92517-5 · Cited by 427
Self-citation
Cited by
Redox signaling: Nitrosylation and related target interactions of nitric oxide
Stamler, J. S. (1994) · Cell · doi:10.1016/0092-8674(94)90269-0 · Cited by 1,723
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Roman, R. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00021.2001 · Cited by 1,309
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 567
STRUCTURE-FUNCTION ASPECTS IN THE NITRIC OXIDE SYNTHASES
Stuehr, D. J. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.339 · Cited by 539
Nitric Oxide: Cytotoxicity versus Cytoprotection— How, Why, When, and Where?
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0118 · Cited by 510
Regulation of Cytochromes P450 During Inflammation and Infection
Morgan, E. T. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002246 · Cited by 488
Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S., & Stemerman, M. B. (1995) · Circulation Research · doi:10.1161/01.res.77.3.510 · Cited by 471
Nitrite as Regulator of Hypoxic Signaling in Mammalian Physiology
van Faassen, E. E., Bahrami, S., Feelisch, M., Hogg, N., Kelm, M., Kim‐Shapiro, D. B., Kozlov, A. V., Li, H., Lundberg, J. O., Mason, R., et al. (2009) · Medicinal Research Reviews · doi:10.1002/med.20151 · Cited by 435
Nitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing Factor
Bauersachs, J., Popp, R., Hecker, M., Sauer, E., Fleming, I., & Busse, R. (1996) · Circulation · doi:10.1161/01.cir.94.12.3341 · Cited by 430
Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Motterlini, R., Foresti, R., Intaglietta, M., & Winslow, R. M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.1.h107 · Cited by 317
Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
(1996) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(96)80006-9 · Cited by 289
Biological nitric oxide signalling: chemistry and terminology
Heinrich, T. A., da Silva, R. S., Miranda, K. M., Switzer, C. H., Wink, D. A., & Fukuto, J. M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12217 · Cited by 285
Hasler, J. A., Estabrook, R., Murray, M., Pikuleva, I., Waterman, M., Capdevila, J., Holla, V., Helvig, C., Falck, J. R., Farrell, G., et al. (1999) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(99)00005-9 · Cited by 267
Inhibition of Cytochrome P450 Enzymes
Correia, M. A., & Hollenberg, P. F. (2015) · Cytochrome P450 · doi:10.1007/978-3-319-12108-6_5 · Cited by 257
Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat
Gardner, C. R., Heck, D. E., Yang, C. S., Thomas, P. E., Zhang, X.-J., DeGeorge, G. L., Laskin, J. D., & Laskin, D. L. (1998) · Hepatology · doi:10.1002/hep.510270316 · Cited by 256
Nitric oxide and S-nitrosothiols in human blood
Giustarini, D., Milzani, A., Colombo, R., Dalle-Donne, I., & Rossi, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00046-9 · Cited by 136
“ing proteins has also been reported [15,16].”
Metadata
- Authors
- Khatsenko, O. G., Gross, S. S., Rifkind, A. B., & Vane, J. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-12
- Volume
- 90
- Issue
- 23
- Pages
- 11147-11151
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2092517767
- Cited by
- 291
- References
- 33
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.